sean patrick mcgraw - Comment

Department of Health and Human Services Docket No. FDA-2011-D-0771j Food and Drug Administration To whom it may concern, I am writing in regards to the FDA's blurprint for prescriber education for the long acting extended release opiod class wide REMS. The proposed rule is to mandate perscribers of these drugs to take continuing education about the perscription of these drugs regarding their side effects and addictive properties. I believe this needs to become law and are is an ideal time with the number of perscribers over-perscribing these medications. Research today shows that opiod pharmacuticals are the leading cause for teenagers who decide to turn to herion. Not just because of their addictive properties, but because of the easy accessibility teenagers have to them. There is a need for all perscribes to become educated on this area. Another partner you may want to consider partnering with is CARE of Southeast Michgan. This orginization is working with state legislatures on this same issue.